BERGEN-PASSAIC COMMUNITY CLINICAL ONCOLOGY PROGRAM

BERGEN-PASSAIC 社区临床肿瘤学计划

• 批准号: 3557473
• 负责人: RICHARD J ROSENBLUTH
• 金额: $ 12.06万
• 依托单位: HACKENSACK UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 1994-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3557473
• 关键词: cancer information system; cancer registry /resource; cancer rehabilitation /care; clinical trials; community health services; continuing education; cooperative study; human subject; human therapy evaluation; neoplasm /cancer education; neoplasm /cancer therapy; patient /disease registry; pediatric neoplasm /cancer; pharmacy administration; primary care physician

The Bergen-Passaic CCOP offers the National Cancer Institute an organization and investigators that have proven their ability to achieve the objectives of the CCOP. As one of the original Community Hospital Oncology Programs (CHOP), and the original CCOP programs, the Bergen-Passaic CCOP has evolved into one of the most advanced cancer programs in the region. For the past seven years, Bergen-Passaic CCOP has met, and will continue to meet, the following aims: to maintain a structural base for planned clinical research and cancer control activities, supporting physician involvement through well managed and well trained staff; to maintain a base of physician support for the total cancer program; to maintain and expand involvement of BPCCOP investigators in the protocols of our research bases; to maintain standards of excellence in all facets of the program; to participate in research base quality control measures; to maintain quality data management activities which emphasize the integration of data collection; to work with our research bases to develop and test useful and scientifically valid cancer control research questions; and to continue to expand both adult and pediatric components of the program. The combination of both a strong adult oncology program, as well as an extensive pediatric oncology program, is a unique feature of the BPCCOP. Due to our seven years of CCOP experience and our prior CHOP experience, BPCCOP offers NCI a seasoned group of adult and pediatric investigators who have an established track record of protocol accrual and quality control. We have conducted cancer control research and evaluation for the past decade, and have involved many primary care physicians and specialists in the oncology program. The pediatric group provides the CCOP with both a unique set of resources and a senior involvement with POG. Solid evaluations from our research base affiliates indicate that our data management team performs superb quality control. BPCCOP offers the NCI an outstanding track record of pediatric and adult protocol accrual to both therapeutic and cancer control research trials. More than a decade of substantial institutional commitment, seasoned staff and an remarkable track record of quality control assures the National Cancer Institute that the BPCCOP will remain an exceptional Community Clinical Oncology Program.

卑尔根-帕塞克CCOP为国家癌症研究所提供了 组织和调查人员已经证明他们有能力实现 CCOP的目标。作为原创的社区医院之一 肿瘤学计划(CHOP)和最初的CCOP计划， 卑尔根-帕塞克慢性阻塞性肺病已演变为最晚期的癌症之一 在该地区的项目。 在过去的七年里，卑尔根-帕塞伊克CCOP已经并将继续 实现以下目标：保持规划的结构基础 临床研究和癌症控制活动，支持医生 通过管理良好、训练有素的工作人员参与；维持基地 医生对整个癌症计划的支持；维持和扩大 BPCCOP调查人员参与我们研究基地的方案； 在计划的所有方面保持卓越的标准； 参与研究基地质量控制措施；维护质量 强调数据整合的数据管理活动 与我们的研究基地合作，开发和测试有用的和 科学有效的癌症控制研究问题；并继续 扩大该计划的成人和儿科部分。 强大的成人肿瘤学课程和 广泛的儿科肿瘤学计划，是BPCCOP的一个独特特点。 由于我们七年的CCOP经验和我们之前的印章经验， BPCCOP为NCI提供了一组经验丰富的成人和儿科调查人员 建立协议应计和质量控制的跟踪记录。 我们过去曾进行过癌症控制研究和评估 十年来，许多初级保健医生和专家参与了 肿瘤学项目。儿科小组为CCOP提供了一个 独一无二的资源和POG的高级参与。实心 我们研究基地附属机构的评估表明，我们的数据 管理团队执行卓越的质量控制。 BPCCOP为NCI提供了出色的儿科和成人记录 该方案在治疗和癌症控制研究试验中均有应用。 十多年的重大机构承诺，经验丰富的员工 卓越的质量控制记录确保了国家 癌症研究所认为BPCCOP仍将是一个特殊的社区 临床肿瘤学课程。